Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$26.2 - $54.0 $107 Million - $221 Million
-4,091,848 Reduced 85.32%
704,000 $24.6 Million
Q1 2022

May 16, 2022

BUY
$38.58 - $83.27 $10.5 Million - $22.7 Million
273,148 Added 6.04%
4,795,848 $237 Million
Q4 2021

Feb 14, 2022

BUY
$75.47 - $135.88 $13.8 Million - $24.8 Million
182,684 Added 4.21%
4,522,700 $350 Million
Q3 2021

Nov 15, 2021

SELL
$95.64 - $131.48 $17.5 Million - $24 Million
-182,676 Reduced 4.04%
4,340,016 $464 Million
Q2 2021

Aug 16, 2021

BUY
$88.13 - $142.06 $104 Million - $168 Million
1,179,568 Added 35.28%
4,522,692 $603 Million
Q1 2021

May 14, 2021

BUY
$105.48 - $207.97 $41.5 Million - $81.9 Million
393,852 Added 13.35%
3,343,124 $414 Million
Q4 2020

Feb 12, 2021

BUY
$76.64 - $167.89 $103 Million - $225 Million
1,339,320 Added 83.19%
2,949,272 $417 Million
Q3 2020

Nov 13, 2020

BUY
$45.46 - $78.79 $41.2 Million - $71.4 Million
905,952 Added 128.69%
1,609,952 $122 Million
Q4 2019

Feb 18, 2020

BUY
$21.0 - $26.48 $14.8 Million - $18.6 Million
704,000 New
704,000 $14.8 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.55B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.